Introduction
Dopamine is a neurotransmitter that functions in the central nervous system to regulate neural processes that include motor control, cognition, and memory. Dysregulation of the DA system is associated with neurological disorders such as Parkinson's disease, schizophrenia, addiction, and ADHD. Five DA receptor (DAR) genes exist in mammals, each of which encodes a DAR subtype (D 1 R -D 5 R), which are grouped by structure and function into the D1-like (D 1 R and D 5 R) and D2-like (D 2 R, D 3 R, and D 4 R) DAR families. The D1-like receptors couple to the G s/olf proteins to activate adenylyl cyclase-mediated formation of cAMP, while the D2-like receptors couple to the G i/o proteins to inhibit adenylyl cyclase (Missale et al., 1998; Sibley and Monsma Jr, 1992) . Several studies, however, have proposed DAR-mediated signaling pathways that do not involve activation of either G i/o or G s/olf proteins.
The first evidence for alternate signaling pathways came from multiple studies reporting "D 1 -like" receptor stimulation of intracellular calcium mobilization suggested to be a result of G qmediated activation of phospholipase C (PLC) (Mahan et al., 1990; Pacheco and Jope, 1997; Undie and Friedman, 1990; Wang et al., 1995) . Subsequently, it was shown that in vitro cell cultures co-expressing the D 1 R and D 2 R could couple to intracellular calcium mobilization through the G q -PLC-diacylglycerol pathway (Lee et al., 2004; Rashid et al., 2007a) . This calcium response required both co-expression and co-activation of both receptor subtypes. This led to the proposal of a "non-canonical" mechanism for DAR-mediated signaling wherein the D 1 R forms a heteromeric complex with the D 2 R and induces PLC-mediated intracellular calcium mobilization (Hasbi et al., 2011; Lee et al., 2004; Rashid et al., 2007b ). The precise mechanism for this type of signaling and its prevalence in vivo, however, remains unclear.
In vivo, there is evidence for (Aizman et al., 2000; Ariano et al., 1997; Lee et al., 2004;  M O L # 8 5 1 7 5 5 appear to co-express D 1 R and D 2 R have neuronal projections that only express D 1 R or only D 2 R (Lee et al., 2004) . This, along with the different methods of detection and visualization, may partially explain the incongruent reports of D 1 R and D 2 R co-localization. However, several recent studies using confocal FRET techniques argue for direct demonstration of the existence of D 1 -D 2 heteromers in 10-20% of the cell bodies and pre-synaptic terminals of medium spiny neurons within the nucleus accumbens (Hasbi et al., 2009; Perreault et al., 2011 Perreault et al., , 2012a , and the two DARs have been shown to co-internalize following selective activation of either receptor (O'Dowd et al., 2005; So et al., 2005) .
Interestingly, several agonists of the benzazepine family seem to exhibit differential effects on the D 1 R monomer versus the proposed D 1 -D 2 heteromer (Rashid et al., 2007b) . One such compound, SKF83822, has been proposed to selectively activate D 1 R-mediated cAMP production while having no effect on calcium mobilization (Rashid et al., 2007a (Rashid et al., , 2007b . In contrast, another benzazepine, SKF83959, has been proposed to selectively activate the heteromer-mediated calcium release and have no effect on cAMP production (Hasbi et al., 2011; Rashid et al., 2007a Rashid et al., , 2007b . More recent studies have used this finding to interpret the results of systemic SKF83959 injections in mice which resulted in increased Ca 2+ /calmodulindependent kinase II phosphorylation and increased brain-derived neurotrophic factor expression in striatal neurons (Hasbi et al., 2009; Ng et al., 2010) . It was also shown that, when injected into rats, expression of glutamate decarboxylase-67 and the vesicular glutamate transporters 1 and 2 in striatal neurons was altered by SKF83959 (Perreault et al., 2012b) , which, again, was interpreted to be due to selective D 1 -D 2 heteromer activation.
In the current study, we further investigate the biology and pharmacology of the proposed D 1 -D 2 heteromer and the mechanism of calcium mobilization in heterologous expression systems. While we find that co-activation of both D 1 R and D 2 R protomers is required for calcium mobilization to occur, there appear to be multiple mechanisms besides G q activation through which this pathway is elicited. We also studied the functional characteristics M O L # 8 5 1 7 5 8 (Freedman et al., 1995; Koch et al., 1994) . For all transfections, 5 μ g of each DNA construct was used to transfect cells, with the exception of D 1 R, in which 10 μ g was used.
Radioligand Binding Assays-48 hr after transfection, cells were dissociated from plates using calcium-free Earle's balanced salt solution (EBSS), and intact cells were collected by centrifugation at 900 × g for 10 min. Cells were resuspended and lysed using 5 mM Tris-HCl (Lee et al., 2004; Rashid et al., 2007a Rashid et al., , 2007b So et al., 2005 (data not shown) as well as other groups (Millan et al., 2001; Seeman and Van Tol, 1993 Beaulieu and Gainetdinov, 2011; Lee et al., 2004; Rashid et al., 2007a Rashid et al., , 2007b . This compound has also been reported to have seemingly paradoxical effects on the D 1 R, exhibiting both antagonist and agonist properties depending on the system (Cools et al., 2002; Panchalingam and Undie, 2001; Zhang et al., 2005) . In our current studies, we treated D 1 R and D 2 R co-transfected cells with SKF83959 and, surprisingly, were unable to elicit a calcium response (Fig. 4A) . Furthermore, when SKF83959 was added in concert with the D 2 R selective agonist quinpirole, we were still unable to observe a significant calcium response. It should be noted that SKF83959 consistently failed to stimulate calcium mobilization even when this experiment was performed using different lots of compound from different vendors on separate days, as well as with different drug solvents (data not shown). We also had one lot of compound chemically analyzed to verify its purity (data not shown). To demonstrate that the SKF83959 compound was pharmacologically active in our hands, we performed two separate experiments. In Fig. 4B , we stimulated calcium mobilization with DA and then dosedependently added either the D 1 R-selective antagonist SCH23390 as a control (see Fig. 2A ) or SKF83959 to see if it might function as an antagonist in this system. In fact it did, exhibiting even higher potency than SCH23390, although its efficacy of antagonism was less, exhibiting a maximum inhibition of ~50%. Finally, we performed a radioligand binding competition assay with SKF83959 and cells transfected with the D 1 R (Fig. 4C) Given the apparent discrepancies of our findings with some previous studies (Hasbi et al., 2011; Lee et al., 2004; Rashid et al., 2007b) , and the possibility that SKF83959 may not be as selective as previously thought, we sought to screen it's selectivity against various GPCRs.
This was accomplished through collaboration with the NIMH Psychoactive Drug-Screening Program (http://pdsp.med.unc.edu). For the primary screen, a single-point radioligand binding competition experiment was performed with 10 μ M SKF83959 as a competitor against an appropriate receptor-specific radioligand of known properties. Forty-three GPCRs and signaling proteins were screened this way and twenty of them resulted in >50% inhibition at 10 μM SKF83959 (Table 1 ). In contrast, twenty-three GPCR targets were found to have <50% inhibition at 10 μM SKF83959 and were therefore considered relatively "inactive/low affinity" for SKF83959 (Supplemental Table 1 Fig. 5A and 5B). No such phenomenon was observed with the D 2 R. Taken together, these data suggest that the G q protein may be involved in calcium mobilization mediated by a D 1 -D 2 heteromer, however, this interpretation is complicated by the fact that overexpression of G qα can also lead to monomeric D 1 R coupling.
Given our results with G qα over-expression, we re-evaluated SKF83959-stimulation of calcium mobilization under these conditions in the D 1 R and D 2 R co-expressed cells. We found that with G qα over-expression, SKF83959 is able to stimulate calcium mobilization in a manner similar to that of DA (Fig. 6A ), whereas it is unable to stimulate such a response in cells lacking G qα over-expression ( Fig. 4 and 6A ). Interestingly, SKF83959 was also able to stimulate calcium mobilization in cells expressing the D 1 R and over-expressing G qα , but not D 1 R alone (Fig. 6A ).
These results led us to test the antagonist sensitivity of the SKF83959 responses as shown in Another possibility, however, may be that general G i -G q "crosstalk" is occurring after receptor activation, which leads to PLC activation. Multiple cases of G i -G q cross-talk in other receptor systems and cell types have been documented (Carroll et al., 1995; Okajima et al., 1989; Rebres et al., 2011; Toms and Roberts, 1999) , and G i -G q cross-talk in the D 1 -D 2 receptor system could account for the PTX sensitivity of the calcium signal. In this model, any Gi-linked GPCR, not just the D 2 R would be able to support a G q -mediated calcium response. In order to test this possibility, we used the D 4 R, a G i -linked DAR, which has not been found to form hetero- heteromer-mediated calcium release, we co-transfected the D 1 R and D 2 R with two different functionally dominant negative G-protein receptor kinase 2 (GRK2) mutants. The mutants we used were GRK2 K220R and the GRK2 C-terminal 495-689 peptide fragment (GRK2 c-term), both of which are unable to phosphorylate GPCRs, but can bind to, and sequester G βγ subunits (Freedman et al., 1995; Koch et al., 1994) . We found that over-expression of GRK2 K220R was able to completely ablate DA-stimulated calcium mobilization in the D 1 R and D 2 R co-transfected cells ( Fig 9A) . Similarly, over-expression of GRK2 c-term drastically reduced, but did not completely ablate, the DA-stimulated calcium response (Fig. 7B ). These data suggest that the observed calcium mobilization occurring in response to D 1 R and D 2 R activation is largely dependent on free G βγ subunits.
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Discussion
Receptor oligomers of many different GPCR types have been proposed to form homoor hetero-oligomers with biochemical and functional characteristics that are unique to their oligomeric conformations (Ferre et al., 2009 ). These GPCR oligomers have been found not only to occur within a type of GPCR, but also across different classes, families, types, and subtypes (Prinster et al., 2005) . In addition to signaling, internalization and degradation of GPCRs in homo-and hetero-oligomers has been found to differ from their monomeric activities (Ferre et al., 2009; Milligan, 2004; Missale et al., 2010; Prinster et al., 2005; Terrillon and Bouvier, 2004) . It has also been proposed that D 1 -D 2 heteromer activation via SKF83959 in vivo and in vitro results in increased calcium/calmodulin-dependent protein kinase IIα levels in the striatum and nucleus accumbens, further resulting in enhanced brain-derived neurotrophic factor expression and increased neuronal maturation and differentiation (Hasbi et al., 2009; Ng et al., 2010; Perreault et al., 2012b; Rashid et al., 2007a (2012) showed that the ghrelin receptor could hetero-oligomerize with the D 2 R. This heteromer induced calcium release from internal cellular stores in a PLC dependent and PTX-sensitive manner, and seemed to require G βγ subunit activation. Previous studies have shown that GRK2 can bind to and sequester G βγ subunits (Koch et al., 1994) and catalytically inactive GRK2 mutants that retain G βγ binding have been used as tools to block G βγ signaling without the complication of added receptor desensitization (Freedman et al., 1995; Koch et al., 1994 has been shown to facilitate weak GTPase-activating protein-like activity on G q , inhibiting PLC actvation. This may explain the difference in degree of calcium signal inhibition between the GRK2 K220R mutant and the truncated GRK2 c-term mutant (Carman et al., 1999) . Therefore, the activation of PLCβ may be G qα -as well as G βγ -dependent and largely due to synergistic crosstalk between the D 1 R and D 2 R. , 6 3 9 -6 4 4 . P a n c h a This article has not been copyedited and formatted. The final version may differ from this version. Figure 4 
